GLP-1 receptors are widely distributed throughout the body including the pancreas, gastrointestinal tract, and central nervous system, which helps explain both their broad therapeutic benefits and their diverse clinical effects
Whether to save money or reduce side effects, there are many reasons people are curious about cycling off and on glucagon-like peptide-1 (GLP-1) weight loss drugs like semaglutide (Ozempic, Wegovy) and orforglipron (Foundayo)
Even off-the-shelf tools require thoughtful integration, compliance validation, and custom logic to support clinical workflows
Research 13 also indicates that GLP-1 medications reduce the activation of appetite- and reward-related brain regions, such as the insula and amygdala, thereby reducing food intake
Large meals may also increase discomfort because GLP-1 medications slow digestion
doi: 10.1210/jc.2012-3855 66 AsmarACramonPKAsmarMSimonsenLSorensenCMMadsbadSet al